v3.26.1
Equity Transactions (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Warrants Outstanding

As of March 31, 2026, the Company had the following warrants outstanding:

 

   Warrants
Outstanding
   Exercise
Price
   Expiration
Date
  Classification 
Q1-22 Warrants   914   $14,329.47   09/09/27    Liability 
December 2022 Warrants   377   $537.26   06/02/28    Equity 
Milestone Warrants   840,000   $17.00   *    Equity 
Prefunded warrants   15,320   $1.88   None    Equity 
    856,611              

 

*The Milestone Warrants expire the earlier of (i) the five-year anniversary of the original issuance date or (ii) the 180th calendar day following the public release by the Company of clinical trial data from the first cohort of the Phase 1 study of ERNA-101.
Schedule of Warrants Activity

The following table shows the warrant activity from January 1, 2026 through March 31, 2026:

 

   Outstanding
January 1,
2026
   Granted   Exercised   Outstanding
March 31,
2026
 
Q1-22 Warrants   914    -    -    914 
December 2022 Warrants   377    -    -    377 
Milestone Warrants   -    840,000    -    840,000 
Prefunded warrants   15,320    80,000    (80,000)   15,320 
Total   16,611    920,000    (80,000)   856,611